Therapeutic Effects of a WeChat Mini-Program on Metabolic Dysfunction–Associated Fatty Liver Disease: Randomized Controlled Trial
Readily scalable in primary care and varied-resource settings, our WeChat mini-program-based intervention extends beyond weight loss to reduce hepatic steatosis and improve metabolic parameters, thereby addressing the critical gap in targeted MAFLD management in China with a low-cost model for high-burden populations. Nevertheless, larger future studies are needed to confirm these findings with greater precision and assess long-term sustainability.
Authors
- Cuicui Shi (ORCID: https://orcid.org/0000-0003-4590-5244)
- Haixia Cao (ORCID: https://orcid.org/0000-0002-8265-9460)
- Jing Zeng (ORCID: https://orcid.org/0000-0001-7764-155X)
- Rui Yang (ORCID: https://orcid.org/0000-0001-9384-6408)
- Guangyu Chen (ORCID: https://orcid.org/0000-0002-9564-8971)
- Xin Sun (ORCID: https://orcid.org/0009-0003-7223-5298)
- Jian‐Gao Fan (ORCID: https://orcid.org/0000-0001-7443-5056)
- C. N. Sun (ORCID: https://orcid.org/0000-0002-0006-1829)
- Xiaoyan Duan (ORCID: https://orcid.org/0000-0002-9049-7641)
Institutions
- XinHua Hospital (CN)
Publication Details
- Journal
- Journal of Medical Internet Research
- Published
- 2025-12-02
- DOI
- https://doi.org/10.2196/76204
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00